CHARACTERISTIC | f | % |
---|---|---|
Region | ||
 Australia and New Zealand | 59 | 37 |
 Canada | 21 | 13 |
 UK and Ireland | 11 | 7 |
 US | 68 | 43 |
 Comparative data from Australia and Canada | 1 | 1 |
n = 160 | ||
Design | f | % |
 Systematic review | 1 | 1 |
 Randomised controlled/cluster trial | 5 | 4 |
 Observational descriptive | 140 | 88 |
 Qualitative | 12 | 8 |
 Mixed methods | 1 | 1 |
 Discussion | 1 | 1 |
n = 160 | ||
Condition | f | % |
 CVD | 84 | 53 |
 COPD | 12 | 8 |
 DM | 43 | 27 |
 CKD | 21 | 13 |
n = 160 | ||
Reporting of mortality | Â | % |
 No | 144 | 90 |
 yes | 16 | 10 |
n = 160 | ||
Reporting of Indigenous dataa | % | |
 No | 120 | 81 |
 Yes | 29 | 19 |
n = 149 | ||
Reporting of service models | Â | % |
 No | 112 | 70 |
 Yes | 48 | 30 |
n = 160 | ||
Reporting of Telehealth | Â | % |
 No | 144 | 90 |
 Yes | 16 | 10 |
n = 160 |